1 UnitedHealth Group Reports Third Quarter 2026 Results
UNITEDHEALTH GROUP INC (UNH) filed an SEC Form 8-K — Results of Operations and Financial Condition. 1 UnitedHealth Group Reports Third Quarter 2026 Results • Third Quarter 2026 Revenues of $112.7 Billion; Earnings from Operations of $6.6 Billion • Earnings of $4.56 Per Share and Adjusted Earnings of $4.69 Per Share • Cash Flows from Operations Were $5.1 Billion, or 1.2x Net Inc
How this was made
The 30-second read
Why it matters
The raised FY2026 earnings outlook may drive buying interest, especially among health‑care focused funds.
Market read
The earnings beat and raised guidance are material for the stock and its sector.
What to watch
Potential regulatory or policy changes affecting Medicare/Medicaid reimbursements could offset the guidance boost.
Third Quarter 2026 Revenues of $112.7 Billion; Earnings from Operations of $6.6 Billion; Earnings of $4.56 Per Share and Adjusted Earnings of $4.69 Per Share
Third-quarter operating earnings, net earnings, EPS and operating margins improved materially from the year-ago quarter, supported by lower medical and operating cost ratios, while consolidated revenue declined and membership and scripts contracted.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Third quarter total revenuesGAAP | $112.7B | – | – |
| Nine months total revenuesGAAP | $336.4B | – | – |
| Third quarter premiums revenueGAAP | $87.08B | – | – |
| Third quarter products revenueGAAP | $14.29B | – | – |
| Third quarter services revenueGAAP | $10.25B | – | – |
| Third quarter investment and other incomeGAAP | $1.08B | – | – |
| Third quarter medical costsGAAP | $76.98B | – | – |
| Third quarter operating costsGAAP | $14.37B | – | – |
| Third quarter cost of products soldGAAP | $13.71B | – | – |
| Third quarter depreciation and amortizationGAAP | $1.07B | – | – |
| Third quarter total operating costsGAAP | $106.1B | – | – |
| Third quarter earnings from operationsGAAP | $6.6B | – | – |
| Nine months earnings from operationsGAAP | $23.54B | – | – |
| Third quarter adjusted earnings from operationsnon-GAAP | $6.26B | – | – |
| Third quarter net marginGAAP | 3.6% | – | – |
| Third quarter medical care ratioother | 88.4% | – | – |
| Third quarter operating cost ratioother | 12.8% | – | – |
| Third quarter net earningsGAAP | $4.3B | – | – |
| Nine months net earningsGAAP | $16.45B | – | – |
| Third quarter net earnings attributable to UnitedHealth Group common shareholdersGAAP | $4.11B | – | – |
| Nine months net earnings attributable to UnitedHealth Group common shareholdersGAAP | $15.87B | – | – |
| Third quarter diluted earnings per share attributable to UnitedHealth Group common shareholdersGAAP | $4.56 | – | – |
| Nine months diluted earnings per share attributable to UnitedHealth Group common shareholdersGAAP | $17.50 | – | – |
| Third quarter adjusted diluted earnings per sharenon-GAAP | $4.69 | – | – |
| Nine months adjusted diluted earnings per sharenon-GAAP | $18.30 | – | – |
| Third quarter cash flows from operationsGAAP | $5.1B | – | – |
| Nine months cash flows from operating activitiesGAAP | $25.09B | – | – |
| Days claims payableother | 47.0 | – | – |
| Days sales outstandingother | 16.9 | – | – |
| Debt-to-capital ratioother | 41.7% | – | – |
| Cash and short-term investmentsGAAP | $28.55B | – | – |
| Long-term debt, less current maturitiesGAAP | $68.71B | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| UnitedHealthcareRevenue compared to $87.1 billion in the third quarter 2025. The business served 48.3 million people, and earnings improvement was driven by benefit changes and pricing discipline, combined with medical and operating cost management. | $86.3B | – | – |
| UnitedHealthcare Employer & IndividualRevenue compared to $19.9 billion in the third quarter 2025. The number of people served contracted by 165,000 in the third quarter 2026 due to employer attrition. | $20.2B | – | – |
| UnitedHealthcare Medicare & RetirementRevenue compared to $43.4 billion in the third quarter 2025 due to changes in membership and product mix. Seniors served through Medicare Advantage, including programs serving complex populations included in Medicaid, have contracted by 935,000 since year-end 2025. | $42.4B | – | – |
| UnitedHealthcare Community & StateRevenue compared to $23.8 billion in the third quarter 2025. People served contracted by 85,000 in the third quarter 2026 due to ongoing Medicaid eligibility changes. | $23.7B | – | – |
| OptumEarnings from operations were $3.7 billion compared to $2.5 billion in the third quarter 2025, while operating margin was 5.6% compared to 3.6%. | $66.9B | – | – |
| Optum HealthRevenue declined as a result of fewer value-based care patients served in markets where Optum lacked sufficient value-based care presence to sustain its clinicians. Earnings from operations were $735 million compared to $41 million, driven by strengthened operational discipline and medical cost management initiatives across value-based care markets. | $22.9B | – | decreased 10% year-over-year |
| Optum InsightEarnings from operations were $1.3 billion compared to $920 million in the third quarter 2025, driven by enhanced product offerings and operational efficiencies. | $5.5B | – | an increase of 3% year-over-year |
| Optum RxEarnings from operations were $1.7 billion compared to $1.5 billion, reflecting continued adoption of biosimilars and operational improvements. Adjusted scripts were 393 million compared to 414 million in the year ago quarter due to membership declines within UnitedHealthcare and other customers. | $39.9B | – | – |
Amounts quoted below without a unit are in millions, as in the filing’s tables. Per-share figures are as printed.
Projected Year Ended December 31, 2026 outlook
- NoteDiluted earnings per share: At least $19.50
- NoteAdjusted diluted earnings per share: At least $20.50
- NoteNet earnings attributable to UnitedHealth Group common shareholders: > $17,650
- NoteAdjusted net earnings attributable to UnitedHealth Group common shareholders: > $18,585
- NoteIntangible amortization: ~1,405
- NoteNet portfolio divestitures and South American impacts: ~(205)
- NoteTax effect of adjustments: ~(265)
- NoteLong-term debt-to-capital ratio target: approximately 40.0% by year-end
Capital returns
- The company repurchased $5.0 billion of its common stock and paid $6.2 billion in dividends year-to-date.
- Nine months common share repurchases were $(5,031).
- Nine months dividends paid were $(6,170).
What drove it
- Third-quarter earnings from operations increased to $6.6 billion from $4.3 billion, driven by disciplined execution across both UnitedHealthcare and Optum.
- The medical care ratio was 88.4% compared to 89.9%, driven by medical cost management initiatives, benefit design changes, pricing discipline and care delivery enhancements focused on affordability and integrated value-based care.
- Medical care ratio included $610 million of net favorable prior period reserve development related to 2026 dates of service.
- The operating cost ratio was 12.8% compared to 13.5%, reflecting realized operating efficiencies partially offset by accelerating investments in technology, processes and people.
- UnitedHealthcare earnings from operations were $2.8 billion compared to $1.8 billion, supported by benefit changes, pricing discipline, medical cost management and operating cost management.
- Optum Health earnings from operations were $735 million compared to $41 million, supported by operational discipline and medical cost management initiatives.
- Optum Insight earnings from operations were $1.3 billion compared to $920 million, driven by enhanced product offerings and operational efficiencies.
- Optum Rx earnings from operations were $1.7 billion compared to $1.5 billion, reflecting continued adoption of biosimilars and operational improvements.
Concerns
- Consolidated third-quarter revenues were $112.7 billion compared to $113.2 billion in the third quarter 2025.
- UnitedHealthcare revenue was $86.3 billion compared to $87.1 billion, while Medicare & Retirement revenue was $42.4 billion compared to $43.4 billion due to changes in membership and product mix.
- The number of people served contracted by 165,000 in UnitedHealthcare Employer & Individual and by 85,000 in Community & State during the third quarter 2026.
- Seniors served through Medicare Advantage, including programs serving complex populations included in Medicaid, have contracted by 935,000 since year-end 2025.
- Optum Health revenue decreased 10% year-over-year due to fewer value-based care patients served in markets where Optum lacked sufficient value-based care presence to sustain its clinicians.
- Optum Rx adjusted scripts were 393 million compared to 414 million in the year ago quarter due to membership declines within UnitedHealthcare and other customers.
- Third-quarter consolidated earnings from operations were $6.6 billion compared to $8.0 billion in the second quarter 2026, and net margin was 3.6% compared to 4.9%.
What to watch
- The trajectory of the 88.4% medical care ratio after $610 million of net favorable prior period reserve development.
- UnitedHealthcare commercial, Medicare Advantage and Medicaid membership trends following reported contractions.
- Whether Optum Health can sustain earnings improvement while its revenue declines from lower value-based care patient volumes.
- Optum Rx script volume after adjusted scripts declined to 393 million from 414 million in the year ago quarter.
- Progress toward the company's approximately 40.0% long-term debt-to-capital ratio target by year-end.
- Execution against the full-year adjusted diluted earnings per share outlook of at least $20.50.
Balance sheet and cash flow
- Cash flows from operations were $5.1 billion, or 1.2x net income, in the third quarter 2026.
- Nine months cash flows from operating activities were $25,087, compared to $18,589.
- Cash and short-term investments were $28,549 as of September 30, 2026, compared to $28,121 as of December 31, 2025.
- Long-term debt, less current maturities, was $68,714 as of September 30, 2026, compared to $72,320 as of December 31, 2025.
- Short-term borrowings and current maturities of long-term debt were $5,617 as of September 30, 2026, compared to $6,069 as of December 31, 2025.
- Debt-to-capital ratio was 41.7% as of September 30, 2026, compared to 41.2% in the second quarter 2026.
- Cash and cash equivalents, end of period, were $25,845, compared to $27,210.
Analysis
UnitedHealth Group reported third-quarter revenue of $112.7 billion, compared with $113.2 billion in the third quarter 2025 and $112.0 billion in the second quarter 2026. Despite the year-over-year revenue decline, earnings from operations increased to $6.6 billion from $4.3 billion and net earnings increased to $4,300 from $2,543. Diluted earnings per share were $4.56, compared with $2.59, while adjusted diluted earnings per share were $4.69 compared with $2.92.
The quarter's earnings improvement was tied to medical and operating-cost execution. The medical care ratio was 88.4%, compared with 89.9% in the year-ago quarter, with management attributing the reduction to medical cost management, benefit design changes, pricing discipline and care delivery enhancements. The ratio also included $610 million of net favorable prior period reserve development related to 2026 dates of service. The operating cost ratio declined to 12.8% from 13.5%, as realized operating efficiencies more than offset accelerating investments in technology, processes and people.
UnitedHealthcare revenue was $86.3 billion, below $87.1 billion a year ago, but operating earnings rose to $2.8 billion from $1.8 billion and operating margin rose to 3.3% from 2.1%. Membership remains a focal point: Employer & Individual people served contracted by 165,000 during the quarter, Community & State people served contracted by 85,000, and seniors served through Medicare Advantage have contracted by 935,000 since year-end 2025. Medicare & Retirement revenue declined to $42.4 billion from $43.4 billion due to membership and product mix changes.
Optum revenue was $66.9 billion compared with $69.2 billion, while operating earnings rose to $3.7 billion from $2.5 billion and operating margin expanded to 5.6% from 3.6%. Optum Health revenue decreased 10% year-over-year to $22.9 billion because of fewer value-based care patients served in markets where Optum lacked sufficient value-based care presence to sustain its clinicians, though its operating earnings improved to $735 million from $41 million. Optum Insight and Optum Rx both reported higher operating earnings, but Optum Rx adjusted scripts declined to 393 million from 414 million.
Cash flows from operations were $5.1 billion, or 1.2x net income, and year-to-date the company repurchased $5.0 billion of common stock and paid $6.2 billion in dividends. The debt-to-capital ratio was 41.7%, above the company's approximately 40.0% long-term target by year-end. Management updated full-year 2026 guidance to at least $19.50 of diluted earnings per share and at least $20.50 of adjusted diluted earnings per share. The reported quarter therefore shows materially improved profitability and cost ratios alongside revenue, membership and script-volume pressure.
Management, verbatim
Our third quarter results reflect the discipline and execution our teams are bringing to every part of our business, as we continue evolving UnitedHealth Group to deliver a simpler, more supportive experience for patients and the clinicians who care for them,
Stephen Hemsley, chief executive officer of UnitedHealth Group
Not in the filing
stated, not guessed- Prior formal outlook was not provided, so comparison of actual results with prior guidance is unavailable.
- Gross margin was not reported.
- Free cash flow was not reported.
- A quarterly cash-flow statement with prior-year quarterly operating cash flow was not reported.
- An effective income tax rate was not reported.
- Forward revenue guidance was not reported.
- Forward gross-margin guidance was not reported.
- Forward operating-expense guidance was not reported.
- Forward tax-rate guidance was not reported.
AlphAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
UnitedHealth Group released its Q3 2026 earnings via an SEC Form 8‑K, highlighting revenue of $112.7 B and adjusted EPS of $4.69.
Ticker impact
UnitedHealth Group filed its 8‑K reporting Q3 2026 results and raised full‑year earnings guidance to at least $19.50 per share.
likely upward pressure as investors price in higher earnings expectations
The company disclosed higher revenue and earnings, and explicitly raised its FY2026 earnings outlook, which typically supports a price rally.
Market effects
Health‑care insurers may see improved sentiment as UnitedHealth signals stronger demand and cost control.
U.S. markets could open higher on the back of the guidance lift.
Large‑cap health‑care stocks worldwide may experience modest gains.
Counterpoint
If the guidance raise is already priced in, the stock could face a short‑term pullback.
Key entities
- companyUnitedHealth Group
U.S. health‑care conglomerate
